Pharma Lobby Disputes Trump’s Claim That Drug Companies Are Negotiating
- President says executives coming this week to talk price cut
- Industry lobby group says it’s not aware of any meeting
Photographer: Rod Lamkey/CNP/Bloomberg
This article is for subscribers only.
The pharmaceutical industry’s leading lobby group said Tuesday it did not know of a meeting at the White House to discuss lowering prescription drug prices, after President Donald Trump said executives were coming in this week to negotiate.
“We are not aware of any meeting,” said Nicole Longo, a spokeswoman for Pharmaceutical Research and Manufacturers of America.